Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Diamond

Showing results (881-890 of 1,028) with videos related to

Pageof 103
Sort By:
Chest|February 1, 1980
Multiple factors in airways obstructionB H Cohen, H A Menkes, W B Bias, et al.
Headache|April 28, 2011
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomesRoger K Cady, Merle L Diamond, Michael P Diamond, et al.
Leukemia & Lymphoma|February 25, 2020
The unique burden of rare cancer caregiving: caregivers of patients with Erdheim-Chester diseaseAllison J Applebaum, Laura C Polacek, Leah Walsh, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugateRobert Bucki, Katarzyna Leszczynska, Fitzroy J Byfield, et al.
Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.
Blood|October 26, 2010
The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapyMoritz Stolla, Lucia Stefanini, R Claire Roden, et al.
Blood Advances|October 25, 2023
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational typeJean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H Durham, et al.
Neurology|May 13, 2021
Intra-arterial Melphalan for Neurologic Non-Langerhans Cell HistiocytosisJasmine H Francis, Y Pierre Gobin, Ruham Alshiekh Nasany, et al.
Headache|April 21, 2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS)Frederick G Freitag, Gary Finlayson, Alan M Rapoport, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Pageof 103

Showing results (881-890 of 1,028) with videos related to

Sort By:
Pageof 103
Chest|February 1, 1980
Multiple factors in airways obstructionB H Cohen, H A Menkes, W B Bias, et al.
Headache|April 28, 2011
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomesRoger K Cady, Merle L Diamond, Michael P Diamond, et al.
Leukemia & Lymphoma|February 25, 2020
The unique burden of rare cancer caregiving: caregivers of patients with Erdheim-Chester diseaseAllison J Applebaum, Laura C Polacek, Leah Walsh, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugateRobert Bucki, Katarzyna Leszczynska, Fitzroy J Byfield, et al.
Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.
Blood|October 26, 2010
The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapyMoritz Stolla, Lucia Stefanini, R Claire Roden, et al.
Blood Advances|October 25, 2023
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational typeJean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H Durham, et al.
Neurology|May 13, 2021
Intra-arterial Melphalan for Neurologic Non-Langerhans Cell HistiocytosisJasmine H Francis, Y Pierre Gobin, Ruham Alshiekh Nasany, et al.
Headache|April 21, 2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS)Frederick G Freitag, Gary Finlayson, Alan M Rapoport, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Pageof 103